Floatz logo

Arcoxia,

Anesthesia

Umeå UniversityN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

29 Active assets in the Anesthesia cohort.

Asset / SponsorPhaseRating
PROPOFOL
Hitit University
Phase 4BB
Bxcl501
Samsung Medical Center
Phase 4BB
Desflurane
Hitit University
Phase 4BB
RAMIFENTANYL
Hitit University
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Faculdade de Ciências Médicas de Minas Gerais
Phase 4BB

View all 44 →

Same molecule, other indications

Arcoxia, is also rated in:

breast neoplasmDormant
D
Indicative ·
30 / 100
View asset →
Regional AnesthesiaDormant
D
Indicative ·
30 / 100
View asset →
iatrogenic diseaseDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →